Rene E Ashworth, MD

Columbia University's Edward Felix Lin, MD specializes in advanced heart failure and transplant cardiology, offering comprehensive care and expertise in cardiovascular disease and internal medicine. With board certifications in cardiovascular disease and internal medicine, Dr. Lin has received extensive training and experience in heart failure, heart transplant, left ventricular assist devices (LVAD), and pulmonary hypertension. He is an Assistant Professor of Medicine at Columbia University Medical Center and is affiliated with NewYork-Presbyterian Columbia University Irving Medical Center.Generated from the website

Luigi Pirelli, MD, earned his medical degree and completed his cardiac surgery training at the University of Milan in Italy, followed by additional surgical training at New York University. He is a cardiac surgeon specializing in transcatheter valve therapies and surgical valve repair. Dr. Pirelli has particular expertise in minimally invasive approaches to complex valvular disease and is committed to collaborative, patient-centered care.

Dr. Geirsson is a renowned cardiac surgeon and the Director of the Cardiovascular Institute and Director of the Surgical Heart Valve Program at NewYork-Presbyterian/Columbia University Irving Medical Center. With an upbringing and medical education in Iceland, he honed his skills in General Surgery at Yale University and Cardiothoracic Surgery at the University of Pennsylvania between 1998 and 2007. During his tenure at Yale as the Director of Minimally Invasive Cardiac Surgery from 2007 to 2013, he made significant contributions to the field. Dr. Geirsson then returned to Iceland from 2013 to 2016, serving as a Cardiothoracic Surgeon at Landspitali University Hospital in Reykjavik. Driven by his passion for innovative approaches, he returned to Yale in 2016 and was appointed as the Chief of the Division of Cardiac Surgery in 2017. Dr. Geirsson's clinical practice focuses on minimally invasive cardiac surgery and valve surgery, specializing in robotic mitral valve repair and aortic valve repair. He achieved notable milestones by performing the first minimally right thoracotomy mitral valve surgery at YNHH in 2009 and the first robotic mitral valve surgery at YNHH in 2018. Moreover, his research endeavors encompass both basic and clinical science, concentrating on mitral valve prolapse and aortic aneurysm disease. With his expertise, dedication, and commitment to advancing cardiac surgery, Dr. Geirsson continues to make significant contributions to the field and improve patient outcomes.